Key Points
-- Non-renounceable entitlement offer to raise up to approximately $10 million (before direct offer costs).
-- Offer price of $0.07 per new share, a 30.0% discount to the closing price of Radiopharm shares on 30 October 2023.
-- All eligible Directors intend to participate in the Offer.
For more information, download the attached PDF.
Download this document
